Regeneron Pharmaceuticals REGN
NASDAQ REGN
$831.63 -11.84 (-1.40%)
As of: Sep 4, 2026 · 2:31 PM EDT

Regeneron Pharmaceuticals (REGN) Operating Margin (QoQ) (2009 - 2026)

Analysis

Regeneron Pharmaceuticals (REGN) Operating Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Incyte 25.61 Bn 21.07 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,232.00
Mar 31, 2026 -482.00
Dec 31, 2025 -470.00
Sep 30, 2025 -202.00
Jun 30, 2025 983.00
Mar 31, 2025 -660.00
Dec 31, 2024 -557.00
Sep 30, 2024 155.00
Jun 30, 2024 626.00
Mar 31, 2024 -444.00
Dec 31, 2023 -471.00
Sep 30, 2023 85.00
Jun 30, 2023 225.00
Mar 31, 2023 -111,686.00
Dec 31, 2022 110,512.00
Sep 30, 2022 283.00
Jun 30, 2022 -360.00
Mar 31, 2022 -1,087.00
Dec 31, 2021 -19.00
Sep 30, 2021 -1,164.00